The yeast ␣-factor pheromone receptor is a member of the G-protein-coupled receptor family. Limited trypsin digestion of yeast membranes was used to investigate ligand-induced conformational changes in this receptor. The agonist, ␣-factor, accelerated cleavage in the third intracellular loop, whereas the antagonist, desTrp1,Ala3-␣-factor, reduced the cleavage rate. Thus, the enhanced accessibility of the third intracellular loop is specific to the agonist. ␣-Factor inhibited cleavage weakly at a second site near the cytoplasmic terminus of the seventh transmembrane helix, whereas the antagonist showed a stronger inhibition of cleavage at this site and at another site in the C-terminal domain of the receptor. The ␣-factor-induced conformational changes appeared to be inherent properties of the receptor, as they were retained in G-protein-deficient mutants. Moreover, a mutant receptor (ste2-L236H) that affects the third loop and is defective for G-protein coupling retained the ability to undergo the agonist-induced conformational changes. These results are consistent with a model in which G-protein activation is limited by the availability of specific contacts between the G protein and the third intracellular loop of the receptor. The antagonist appears to promote a distinct conformational state that differs from either the unoccupied or the agonist-occupied state.Receptors coupled to heterotrimeric GTP-binding proteins (G proteins) contain seven transmembrane helices and control cellular responses to a variety of stimuli, including hormones, neurotransmitters, light, and odorants (2, 13, 46). It is widely believed that the conformational changes induced by agonist binding permit these receptors to associate productively with G proteins, thus resulting in the exchange of GDP for GTP in the G ␣ subunit. Three lines of evidence suggest that the third intracellular loop of the receptor provides at least some of the intermolecular contacts that promote guanine nucleotide exchange: (i) work with chimeric receptors indicates that the third intracellular loop influences the specificity of G-protein interactions (13); (ii) mutations in the third intracellular loop (2,11,46,48) block coupling of receptors to their respective G proteins; and (iii) synthetic peptides that comprise the third loop bind G proteins in vitro, thereby stimulating nucleotide exchange and blocking the association of the G protein with the receptor (47). It has been proposed that structural constraints in receptors prevent the third intracellular loop from contacting the G protein when agonists are absent and that these structural constraints are relieved when the receptor assumes an agonist-activated conformation (36). However, there is as yet no direct evidence which demonstrates that increased exposure of the third intracellular loop is a specific consequence of agonist binding.The ability of ligands to promote changes in protein conformation has been largely pioneered by studying hemoglobin and allosteric enzymes (1, 37, 41). In general, alloster...